Logo

Discovery Life Sciences: Suso Platero

Sep 29, 2022

Suso Platero has joined Discovery Life Sciences as CSO. He comes to the Huntsville, Alabama-based biosamples and biomarker firm from Vertex Pharmaceuticals, where he was VP of biomarkers, imaging, and diagnostics. Prior to that, he worked at Labcorp, where he designed and led the development of a biomarker solution center for cell and gene therapy, immune-oncology, and oncology. He also previously managed oncology translational research teams at Janssen Pharmaceutical Companies and a clinical biomarker team at Bristol-Myers Squibb.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.